S&P 500   4,567.80
DOW   35,950.89
QQQ   388.83
The top-rated strong-buy stocks on Marketbeat’s radar
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Marketbeat’s AI-powered tools for investors
Are blue chip stocks a good investment?
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
As Dollar Tree Goes, So Goes the Consumer?
Power Play: GE's game-changing technology for EVs and grids
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Is Beyond an overlooked e-commerce winner?
Inflation in Europe falls to 2.4% as interest rates pack a punch. But the economy has stalled
S&P 500   4,567.80
DOW   35,950.89
QQQ   388.83
The top-rated strong-buy stocks on Marketbeat’s radar
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Marketbeat’s AI-powered tools for investors
Are blue chip stocks a good investment?
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
As Dollar Tree Goes, So Goes the Consumer?
Power Play: GE's game-changing technology for EVs and grids
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Is Beyond an overlooked e-commerce winner?
Inflation in Europe falls to 2.4% as interest rates pack a punch. But the economy has stalled
S&P 500   4,567.80
DOW   35,950.89
QQQ   388.83
The top-rated strong-buy stocks on Marketbeat’s radar
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Marketbeat’s AI-powered tools for investors
Are blue chip stocks a good investment?
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
As Dollar Tree Goes, So Goes the Consumer?
Power Play: GE's game-changing technology for EVs and grids
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Is Beyond an overlooked e-commerce winner?
Inflation in Europe falls to 2.4% as interest rates pack a punch. But the economy has stalled
S&P 500   4,567.80
DOW   35,950.89
QQQ   388.83
The top-rated strong-buy stocks on Marketbeat’s radar
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Marketbeat’s AI-powered tools for investors
Are blue chip stocks a good investment?
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
As Dollar Tree Goes, So Goes the Consumer?
Power Play: GE's game-changing technology for EVs and grids
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Is Beyond an overlooked e-commerce winner?
Inflation in Europe falls to 2.4% as interest rates pack a punch. But the economy has stalled

Mind Medicine (MindMed) Stock Price, News & Analysis (OTCMKTS:MMEDF)

$3.30
+0.06 (+1.85%)
(As of 11/30/2023 ET)
Compare
Today's Range
$3.19
$3.36
50-Day Range
$2.43
$3.70
52-Week Range
$0.29
$5.07
Volume
454,655 shs
Average Volume
3.38 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

MMEDF stock logo

About Mind Medicine (MindMed) Stock (OTCMKTS:MMEDF)

Mind Medicine (MindMed) Inc., a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The company is headquartered in New York, New York.

MMEDF Stock Price History

MMEDF Stock News Headlines

Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
Mind Medicine (MindMed), Inc.
8-K: Mind Medicine (MindMed) Inc.
Why Microsoft Just Placed A Huge Bet On Nuclear
Even with aggressive expansion and acquisition of solar and wind farms, renewable energy isn’t anywhere close to providing the energy that Microsoft demands.
Why Mind Medicine Stock Triumphed on Tuesday
Mind Medicine Inc (MNMD)
Why MindMed Stock Is Tanking Today
See More Headlines
Receive MMEDF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mind Medicine (MindMed) and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:MMEDF
CIK
N/A
Phone
N/A
Fax
N/A
Employees
22
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Jamon Alexander Rahn
    Co-Founder, CEO & Director
  • Dr. Miriam Halperin Wernli
    Exec. Pres & Director
  • Dr. Scott M. Freeman (Age 64)
    Co-Founder & Clinical Advisor
  • Mr. Leonard Latchman
    Co-founder
  • Mr. David Dean Guebert
    Chief Financial Officer
  • Ms. Carol Nast
    Chief Operating Officer
  • Mr. Bradford Cross
    Chief Technology Officer
  • Dr. Donald R. Gehlert Ph.D.
    Chief Scientific Officer & Member of Scientific Advisory Board
  • Ms. Madeline Feldman
    Director of Operations & Admin.
  • Mr. Collin Gage
    VP of Corp. Devel.














MMEDF Stock Analysis - Frequently Asked Questions

How have MMEDF shares performed in 2023?

Mind Medicine (MindMed)'s stock was trading at $2.20 at the beginning of 2023. Since then, MMEDF stock has increased by 50.0% and is now trading at $3.30.
View the best growth stocks for 2023 here
.

How do I buy shares of Mind Medicine (MindMed)?

Shares of MMEDF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (OTCMKTS:MMEDF) was last updated on 12/1/2023 by MarketBeat.com Staff

My Account -